{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:11:50Z","timestamp":1790115110069,"version":"4.0.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02213-9","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T06:21:28Z","timestamp":1739427688000},"page":"1737-1742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis"],"prefix":"10.1093","volume":"38","author":[{"given":"Yukako","family":"Umezawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-1741","authenticated-orcid":false,"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2213_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN (2021) IgA nephropathy: core curriculum 2021. Am J Kidney Dis 78:429\u2013441. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.024","journal-title":"Am J Kidney Dis"},{"key":"2213_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ekir.2019.10.012","volume":"5","author":"M Wang","year":"2019","unstructured":"Wang M, Lv J, Zhang X, Chen P, Zhao M, Zhang H (2019) Secondary IgA nephropathy shares the same immune features with primary IgA nephropathy. Kidney Int Rep 5:165\u2013172. https:\/\/doi.org\/10.1016\/j.ekir.2019.10.012","journal-title":"Kidney Int Rep"},{"key":"2213_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000708","volume":"3","author":"MS Hommos","year":"2017","unstructured":"Hommos MS, El-Zoghby ZM (2017) Renal outcomes in patients with IgA nephropathy undergoing liver transplant: a retrospective cohort study. Transplant Direct 3:e193. https:\/\/doi.org\/10.1097\/TXD.0000000000000708","journal-title":"Transplant Direct"},{"key":"2213_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12882-017-0769-1","volume":"18","author":"D Takada","year":"2017","unstructured":"Takada D, Sumida K, Sekine A, Hazue R, Yamanouchi M, Suwabe T, Hayami N, Hoshino J, Sawa N, Takaichi K, Fujii T, Ohashi K, Ubara Y (2017) IgA nephropathy featuring massive wire loop-like deposits in two patients with alcoholic cirrhosis. BMC Nephrol 18:362. https:\/\/doi.org\/10.1186\/s12882-017-0769-1","journal-title":"BMC Nephrol"},{"key":"2213_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00281-021-00883-8","volume":"43","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Novak J (2021) IgA glycosylation and immune complex formation in IgAN. Semin Immunopathol 43:669\u2013678. https:\/\/doi.org\/10.1007\/s00281-021-00883-8","journal-title":"Semin Immunopathol"},{"key":"2213_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","volume":"93","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y (2018) IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int 93:700\u2013705. https:\/\/doi.org\/10.1016\/j.kint.2017.10.019","journal-title":"Kidney Int"},{"key":"2213_CR7","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/ndt\/gfz152","volume":"35","author":"CA Cassol","year":"2020","unstructured":"Cassol CA, Bott C, Nadasdy GM, Alberton V, Malvar A, Nagaraja HN, Nadasdy T, Rovin BH, Satoskar AA (2020) Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy. Nephrol Dial Transplant 35:2123\u20132129. https:\/\/doi.org\/10.1093\/ndt\/gfz152","journal-title":"Nephrol Dial Transplant"},{"key":"2213_CR8","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1681\/ASN.2019100987","volume":"31","author":"A Takahata","year":"2020","unstructured":"Takahata A, Arai S, Hiramoto E, Kitada K, Kato R, Makita Y, Suzuki H, Nakata J, Araki K, Miyazaki T, Suzuki Y (2020) Crucial role of AIM\/CD5L in the development of glomerular inflammation in IgA nephropathy. J Am Soc Nephrol 31:2013\u20132024. https:\/\/doi.org\/10.1681\/ASN.2019100987","journal-title":"J Am Soc Nephrol"},{"key":"2213_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/ki.2011.276","volume":"80","author":"E Tissandi\u00e9","year":"2011","unstructured":"Tissandi\u00e9 E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawal\u00e9 JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC (2011) Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int 80:1352\u20131363. https:\/\/doi.org\/10.1038\/ki.2011.276","journal-title":"Kidney Int"},{"key":"2213_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10157-016-1240-5","volume":"21","author":"M Oshima","year":"2017","unstructured":"Oshima M, Iwata Y, Furuichi K, Sakai N, Shimizu M, Hara A, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Umeda E, Kaneko S, Arai S, Miyazaki T, Wada T (2017) Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunction. Clin Exp Nephrol 21:35\u201342. https:\/\/doi.org\/10.1007\/s10157-016-1240-5","journal-title":"Clin Exp Nephrol"},{"key":"2213_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ekir.2024.02.1397","volume":"9","author":"C Ronsin","year":"2024","unstructured":"Ronsin C, Braud P, Kandel-Aznar C, Dujardin A, Petit C, Larmet D, Garandeau C, Deltombe C, Le Clech A, Leman C, Blancho G, Schurder J, Couvrat-Desvergnes G, Ville S (2024) Clinical presentation, pathological spectrum, and outcomes of alcoholic cirrhosis-related IgA nephropathy. Kidney Int Rep 9:1369\u20131378. https:\/\/doi.org\/10.1016\/j.ekir.2024.02.1397","journal-title":"Kidney Int Rep"},{"key":"2213_CR12","doi-asserted-by":"publisher","first-page":"1331757","DOI":"10.3389\/fneph.2023.1331757","volume":"3","author":"Y Yoshimura","year":"2024","unstructured":"Yoshimura Y, Ikuma D, Mizuno H, Kono K, Kinowaki K, Sugimoto H, Kamido H, Sawada Y, Mizuta M, Kurihara S, Oba Y, Yamanouchi M, Suwabe T, Ohashi K, Ubara Y, Sawa N (2024) Efficacy of SGLT2 inhibitors in IgA nephropathy associated with alcoholic liver cirrhosis accompanied by nephrotic syndrome: a case report. Front Nephrol 3:1331757. https:\/\/doi.org\/10.3389\/fneph.2023.1331757","journal-title":"Front Nephrol"},{"issue":"4S","key":"2213_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4S):S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02213-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:34Z","timestamp":1777564774000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/6\/1737\/8457531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2213"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02213-9","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This case was conducted ethically in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No animals were involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"The authors declare that informed consent was obtained from the patient reported in this article for publication of the information presented within this case report and any associated supplementary material.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}